Preface |
|
v | |
Acknowledgment |
|
vii | |
Contributors |
|
xiii | |
|
|
xvii | |
|
Part I. Melanocyte Development and Function |
|
|
|
The Origin and Development of Neural Crest-Derived Melanocytes |
|
|
3 | (24) |
|
|
|
MITF: A Matter of Life and Death for Developing Melanocytes |
|
|
27 | (24) |
|
|
|
|
|
|
|
|
|
|
MITF: Critical Regulator of the Melanocyte Lineage |
|
|
51 | (20) |
|
|
|
|
Melanocytes and the Transcription Factor Sox 10 |
|
|
71 | (10) |
|
|
Human Cutaneous Pigmentation: A Collaborative Act in the Skin, Directed by Paracrine, Autocrine, and Endocrine Factors and the Environment |
|
|
81 | (20) |
|
|
|
Melanocyte Distribution and Function in Human Skin: Effects of Ultraviolet Radiation |
|
|
101 | (18) |
|
|
|
Part II. Melanocyte Transformation and Progression to Melanoma |
|
|
|
Altered Signal Transduction in Melanoma |
|
|
119 | (30) |
|
|
|
|
BRN2 in Melanocytic Cell Development, Differentiation, and Transformation |
|
|
149 | (20) |
|
|
|
|
|
|
The Dynamic Roles of Cell-Surface Receptors in Melanoma Development |
|
|
169 | (14) |
|
|
|
Familial Melanoma Genes, Melanocyte Immortalization, and Melanoma Initiation |
|
|
183 | (14) |
|
|
Genetic Progression From Melanocyte to Malignant Melanoma |
|
|
197 | (14) |
|
|
The Multiple Roles of the Oncogenic Protein SKI in Human Malignant Melanoma |
|
|
211 | (12) |
|
|
|
|
|
|
RB/E2F Regulation and Dual Activity in the Melanocytic System |
|
|
223 | (24) |
|
|
Melanoma Development and Pigment Cell Transformation |
|
|
247 | (18) |
|
|
The Biology and Genetics of Melanoma |
|
|
265 | (26) |
|
|
|
The Biology of Xeroderma Pigmentosum: Insights Into the Role of Ultraviolet Light in the Development of Melanoma |
|
|
291 | (20) |
|
|
Divergent Pathways to Cutaneous Melanoma |
|
|
311 | (18) |
|
|
|
Pigmentation, DNA Repair, and Candidate Genes: The Risk of Cutaneous Malignant Melanoma in a Mediterranean Population |
|
|
329 | (18) |
|
|
Low-Penetrance Genotypes, Pigmentation Phenotypes, and Melanoma Etiology |
|
|
347 | (18) |
|
|
|
The Biology of Melanoma Progression: From Melanocyte to Metastatic Seed |
|
|
365 | (34) |
|
|
|
|
Optical Imaging Analysis of Atypical Nevi and Melanoma |
|
|
399 | (10) |
|
|
|
Proteomics Analysis of Melanoma Cell Lines and Cultured Melanocytes |
|
|
409 | (20) |
|
|
|
Part III. Primary Invasive Melanoma to Metastatic Melanoma |
|
|
|
Paradigm of Metastasis for Malignant Melanoma |
|
|
429 | (12) |
|
|
Repair of UV-Induced DNA Damage and Melanoma Risk |
|
|
441 | (14) |
|
|
High-Risk Factors for Melanoma Metastasis |
|
|
455 | (20) |
|
|
|
Role of Melanoma Inhibitory Activity in Early Development of Malignant Melanoma |
|
|
475 | (14) |
|
|
Role and Regulation of PAR-1 in Melanoma Progression |
|
|
489 | (14) |
|
|
|
Molecular Mechanisms of Melanoma Metastasis |
|
|
503 | (10) |
|
|
Overview of Tumor Progression in Melanoma |
|
|
513 | (20) |
|
|
The Plasticity of Melanoma Cells and Associated Clinical Implications |
|
|
533 | (18) |
|
|
|
|
|
The Clinical Use of Molecular Markers as Predictors of Disease Outcome and Response to Therapy in Malignant Melanoma |
|
|
551 | (26) |
|
|
|
|
The Role of DCT/TYRP2 in Resistance of Melanoma Cells to Drugs and Radiation |
|
|
577 | (14) |
|
|
|
How Melanoma Cells Evade Chemotherapy: Role of Transporter-Dependent and -Independent Resistance Mechanisms |
|
|
591 | (14) |
|
|
|
Apoptosis in Melanoma: Approaches to Therapy |
|
|
605 | (14) |
|
|
|
Role of Melanoma-Associated Antigens |
|
|
619 | (14) |
|
|
|
|
Host Responses to Melanoma: Implications for Immunotherapy |
|
|
633 | (18) |
|
|
|
|
651 | (2) |
|
|
Index |
|
653 | |